Acadia Healthcare Q2 revenue up 12.2%; raises FY2023 guidance; acquires Turning Point Centers

Acadia Healthcare Company, Inc.

2023-Q2 EPS reported $1.51 revenue$1,435,604,000

Revenue $731.3M, up 12.2% YoY; adjusted EPS $0.92 vs $0.79 GAAP.
Adjusted EBITDA $174.5M, up 10.9% YoY, excluding $8.6M CARES Act income.
Raised FY2023 guidance: revenue $2.86-2.90B, adjusted EPS $3.25-3.50, adj. EBITDA $655-685M.
Signed definitive agreement to acquire Turning Point Centers (76-bed specialty provider in Utah); expected close in 2023.
Added 98 beds to existing facilities in Q2, totaling 204 beds in H1 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Acadia Healthcare Company, Inc. reported the second quarter ended June 30, 2023 results: revenue $731.3 million, net income $72.3 million, EPS $0.79 per diluted share. Guidance raised.

Period: the second quarter ended June 30, 2023
Revenue: $731.3 million
Net income: $72.3 million
EPS: $0.79 per diluted share
Guidance: raised
Result: reported results

Exact text from the filing

Company, Inc. (“Acadia”) (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2023. Second Quarter and Recent Highlights Revenue totaled $731.3 million, an increase of 12.2% over the second quarter of 2022 Same facility revenue increased 11.4% compared with the second quarter of 2022, including an increase in revenue per patient

View on SEC.gov

Browse all earnings releases →

Acadia Healthcare Company, Inc. filing history →

Source: SEC EDGAR

accession 0001157523-23-001176

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.